- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Neuroscouting, L.L.C.
Total 582 results
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedRed-Cell Aplasia, Pure | Chronic Renal Failure
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedMood Disorders | Bipolar DisorderUnited States, Taiwan, Russian Federation, Turkey, Ukraine, Greece, Korea, Republic of, Lithuania
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedAsthmaUnited States, Costa Rica, India
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedPsychotic Disorders | SchizophreniaUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedMetabolic Diseases | Obesity | Nutrition Disorders | Overweight | Nutritional and Metabolic DiseasesUnited Kingdom, Germany, Belgium, Netherlands, Finland, Sweden, Denmark
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedInterstitial CystitisUnited States, Canada
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedAnemia | Renal DiseasesUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophreniaUnited States, India, Romania, Russian Federation, Ukraine
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedEpilepsy | Seizures | Partial Seizure DisorderUnited States, Australia, France, Belgium, Taiwan, Spain, Argentina, Poland, India, Ukraine, Finland, Korea, Republic of, Russian Federation, Chile, Thailand, Hungary, Israel, New Zealand, Canada, Mexico, Norway, Netherlands, South...
-
Johnson & Johnson Pharmaceutical Research & Development...Completed21-hydroxylase DeficiencyUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedHealthy ParticipantsBelgium
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSeasonal Allergic RhinitisCanada
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2United States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2United States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedHealthy | Renal InsufficiencyUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedHepatic Insufficiency | HealthyUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedRheumatoid ArthritisPoland, United Kingdom, Taiwan, Spain, Korea, Republic of, Belgium, Russian Federation, Czech Republic, Netherlands, Ireland
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedMetabolic Diseases | Obesity | Nutrition Disorders | Overweight | Nutritional and Metabolic DiseasesFinland, Sweden, Netherlands
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophrenia | Bipolar Disorder | Autistic Disorder | Conduct and Other Disruptive Behavior DisordersUnited States, Belgium, Germany, Poland, Greece, Netherlands
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Pamlab, L.L.C.HealthCore, Inc.CompletedDiabetic Peripheral Neuropathy (DPN)United States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Pamlab, L.L.C.InfoMedics, Inc.UnknownDiabetic Peripheral NeuropathyUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophrenia | Renal Impairment
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedObesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Adult-Onset
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFrontotemporal Dementia | Pick Complex
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedContraception | Pharmacokinetics | Drug Interactions
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedObesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Adult-Onset
-
Johnson & Johnson Pharmaceutical Research & Development...Completed